Document Report Card

Basic Information

ID: ALA4665658

Journal: Bioorg Med Chem Lett

Title: Quinoline and thiazolopyridine allosteric inhibitors of MALT1.

Authors: Scott DA,Hatcher JM,Liu H,Fu M,Du G,Fontán L,Us I,Casalena G,Qiao Q,Wu H,Melnick A,Gray NS

Abstract: Quinolines and thiazolopyridines were developed as allosteric inhibitors of MALT1, with good cellular potency and exquisite selectivity. Mouse pharmacokinetic (PK) profiling showed these to have low in vivo clearance, and moderate oral exposure. The thiazolopyridines were less lipophilic than the quinolines, and one thiazolopyridine example was active in our hIL10 mouse pharmacodynamic (PD) model upon oral dosing.

CiteXplore: 31129051

DOI: 10.1016/j.bmcl.2019.05.040